Advocacy intelligence hub — real-time data for patient organizations
HELP Therapeutics Co., Ltd. — PHASE1, PHASE2
Dermavon Holdings Limited — PHASE2
Dermavon Holdings Limited — PHASE2, PHASE3
Shenzhen Kangzhe Biotechnology Co., Ltd. — PHASE2
Truway Health, Inc.
Third Military Medical University — NA
National Institute of Neurological Disorders and Stroke (NINDS)
HELP Therapeutics Co., Ltd. — PHASE1, PHASE2
The Foundation for Orthopaedics and Regenerative Medicine — PHASE1
argenx — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Andrew G Engel, MD
Mayo Clinic
Laurent Servais, MD
Centre Hospitalier Universitaire de Liege
Christopher Grunseich, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
📍 Bethesda, Maryland
Thomas Crawford, M.D.
Johns Hopkins Pediatric Neurology
Laurent SERVAIS, MD, PhD
institut myologie
Simon Edvardson
Hadassah Medical Organization